Tiarne van de Walle

Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma

T. O. Bontell, A. Jakola, M. Essand, 2021, bioRxiv.

Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma

M. Essand, A. Dimberg, I. Pietilä, 2021, Frontiers in Immunology.

Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma

A. Jakola, M. Essand, M. Zetterling, 2021, Nature Communications.

ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma

F. Pontén, E. Dejana, Liqun He, 2021, Neuro-oncology.

Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma.

A. Jakola, M. Essand, B. Westermark, 2023, Cancer cell.

Cellular and molecular events organizing the assembly of tertiary lymphoid structures in glioblastoma

A. Jakola, T. Olsson Bontell, A. Dimberg, 2024, bioRxiv.